Team:Sharon BasicallyAcid
From 2012hs.igem.org
Line 5: | Line 5: | ||
<html> | <html> | ||
+ | |||
<head> | <head> | ||
- | <style> | + | <style type="text/css"> |
+ | #globalwrapper { | ||
+ | width:975px; | ||
+ | padding:20px 0px; | ||
+ | margin: 0 auto; | ||
+ | background-color:#ffffff; | ||
+ | height:100%; | ||
+ | } | ||
+ | .firstHeading { | ||
+ | height:0px; | ||
+ | visibility:hidden; | ||
+ | } | ||
+ | body { | ||
+ | background: #E8E8E8; | ||
+ | background-image: url('https://static.igem.org/mediawiki/2011/b/be/Background-gradient.jpg'); | ||
+ | background-position: center; | ||
+ | background-repeat: repeat-y; | ||
+ | } | ||
+ | #p-logo { | ||
+ | height:1px; overflow:hidden; display: none; | ||
+ | } | ||
#top-section { | #top-section { | ||
Line 17: | Line 38: | ||
} | } | ||
- | + | ||
- | + | ||
- | + | #content { | |
- | + | border-left-width:0px; | |
- | + | border-right-width:0px; | |
- | + | padding:5px; | |
- | + | width:965px; | |
} | } | ||
- | + | #menubar { | |
- | + | background-color: white; | |
- | + | ||
- | + | ||
} | } | ||
- | + | #menubar ul li a { | |
- | . | + | color: #999999; } |
- | + | .right-menu li a { | |
- | + | color: black; | |
+ | background-color: white; | ||
} | } | ||
- | . | + | |
- | . | + | #navbar |
- | font-weight: | + | ul.navbar { |
+ | float:left; | ||
+ | width:100%; | ||
+ | padding:0; | ||
+ | margin:0; | ||
+ | list-style-type:none; | ||
+ | } | ||
+ | |||
+ | ul.navbar a { | ||
+ | float:left; | ||
+ | text-align:center; | ||
+ | width:7em; | ||
+ | text-decoration:none; | ||
+ | color:white; | ||
+ | background-color:#1A2B32; | ||
+ | padding:0.2em 0.6em; | ||
+ | border-right:1px solid white; | ||
+ | } | ||
+ | ul.navbar a:hover {background-color:#A3ABAE;} | ||
+ | ul.navbar li {display:inline;} | ||
+ | |||
+ | #long { | ||
+ | width:10em; | ||
+ | } | ||
+ | |||
+ | |||
+ | .navbar { | ||
+ | padding:0 20px; | ||
+ | } | ||
+ | |||
+ | </style> | ||
+ | </head> | ||
+ | |||
+ | <body> | ||
+ | |||
+ | |||
+ | <!--navigation menu--> | ||
+ | <ul class="navbar"> | ||
+ | <li><a href="https://2012hs.igem.org/Team:Sharon_MA_Aquila">HOME</a></li> | ||
+ | <li><a href="https://2012hs.igem.org/Team:Sharon_MA_Aquila/Team">TEAM</a></li> | ||
+ | <li><a href="https://2012hs.igem.org/Team:Sharon_MA_Aquila/Project">PROJECT</a></li> | ||
+ | <li><a href="https://2012hs.igem.org/Team:Sharon_MA_Aquila/Results">RESULTS</a></li> | ||
+ | <li><a href="https://2012hs.igem.org/Team:Sharon_MA_Aquila/Notebook">NOTEBOOK</a></li> | ||
+ | <li><a href="https://2012hs.igem.org/Team:Sharon_MA_Aquila/Safety">SAFETY</a></li> | ||
+ | <li><a id="long" href="https://2012hs.igem.org/Team:Sharon_MA_Aquila/HumanPractices">HUMAN PRACTICES</a></li> | ||
+ | <li><a id="long" href="https://2012hs.igem.org/Team:Sharon_MA_Aquila/Attributions">ATTRIBUTIONS</a></li> | ||
+ | </ul> | ||
+ | |||
+ | </body> | ||
+ | </html> | ||
+ | |||
+ | <html lang="en"> | ||
+ | <head> | ||
+ | <style type="text/css"> | ||
+ | |||
+ | a { | ||
+ | color: #991133; | ||
+ | text-decoration: none; | ||
+ | } | ||
+ | |||
+ | a:hover { | ||
+ | text-decoration: underline; | ||
+ | } | ||
+ | |||
+ | #minimalist { | ||
+ | font-family:"Lucida Sans Unicode", "Lucida Grande", Sans-Serif; | ||
+ | font-size:9px; | ||
+ | width: 100%; | ||
+ | background:#fff; | ||
+ | border-collapse:collapse; | ||
+ | text-align:left; | ||
+ | margin:20px; | ||
+ | } | ||
+ | |||
+ | #minimalist th { | ||
+ | font-size:10px; | ||
+ | font-weight:normal; | ||
+ | color:#039; | ||
+ | border-bottom:2px solid #6678b1; | ||
+ | padding:10px 8px; | ||
+ | } | ||
+ | |||
+ | #minimalist td { | ||
+ | color:#669; | ||
+ | padding:9px 8px 0; | ||
+ | } | ||
+ | |||
+ | .clear { | ||
+ | clear:both; | ||
+ | } | ||
+ | |||
+ | #col_left{ | ||
+ | float: left; | ||
+ | width: 576px; | ||
+ | padding: 30px 0px; | ||
+ | margin:0; | ||
+ | } | ||
+ | #col_right{ | ||
+ | float: right; | ||
+ | width: 242px; | ||
+ | padding: 30px 28px 30px 15px; | ||
+ | margin:0; | ||
+ | } | ||
+ | #col_center{ | ||
+ | float: center; | ||
+ | width: 576; | ||
+ | padding: 30px 100px; | ||
+ | margin:0; | ||
+ | } | ||
+ | #col_nav{ | ||
+ | float: left; | ||
+ | width: 200px; | ||
+ | padding: 30px 15px 30px 50px; | ||
+ | margin:0; | ||
+ | } | ||
+ | #block-content{ | ||
+ | padding-bottom: 15px; | ||
+ | clear:both; | ||
+ | } | ||
+ | |||
+ | #gold_sponsors{ | ||
+ | float: left; | ||
+ | width: 197px; | ||
+ | margin-right: 17px; | ||
+ | display: inline; | ||
+ | } | ||
+ | #gold_sponsors h3{ | ||
+ | color: #FFBE30; | ||
+ | text-align:center; | ||
+ | } | ||
+ | #gold_sponsors ul{ | ||
+ | background-color: #FFF1C4; | ||
+ | } | ||
+ | #partners{ | ||
+ | float: left; | ||
+ | width: 175px; | ||
+ | margin-right: 17px; | ||
+ | display: inline; | ||
+ | } | ||
+ | #partners h3{ | ||
+ | text-align:center; | ||
+ | } | ||
+ | #contributing_departments{ | ||
+ | float: left; | ||
+ | width: 170px; | ||
+ | display: inline; | ||
+ | } | ||
+ | #contributing_departments h3{ | ||
+ | text-align:center; | ||
+ | } | ||
+ | #partners ul, #contributing_departments ul, #gold_sponsors ul{ | ||
+ | list-style-type:none; | ||
+ | list-style-image:none; | ||
+ | margin-left:0px; | ||
+ | } | ||
+ | #partners li, #contributing_departments li, #gold_sponsors li{ | ||
+ | margin-left: 0px; | ||
+ | } | ||
+ | #partners img, #contributing_departments img, #gold_sponsors img{ | ||
+ | border: 1px solid #ccc; | ||
+ | } | ||
+ | h3{ | ||
+ | padding: 30px 0 20px 0; | ||
+ | font-family: "Lucida Sans Unicode", "Lucida Grande", Sans-Serif; | ||
+ | font-size: 18px; | ||
+ | font-weight: normal; | ||
+ | } | ||
+ | |||
+ | #center{ | ||
+ | float:left; | ||
+ | padding-bottom: 35px; | ||
+ | margin-bottom:10px; | ||
+ | border-top: 1px dotted #999; | ||
+ | border-bottom: 1px dotted #999; | ||
+ | clear:both; | ||
+ | padding-left: 50px; | ||
+ | padding-right: 50px; | ||
+ | } | ||
+ | #quote{ | ||
+ | float:left; | ||
+ | padding: 0 25px 25px 25px; | ||
+ | font-family: Georgia, "Times New Roman", Times, serif; | ||
+ | font-size: 17px; | ||
+ | font-style: italic; | ||
+ | letter-spacing: 2px; | ||
+ | color: #333; | ||
+ | } | ||
+ | #quote p{ | ||
+ | line-height: 22px; | ||
+ | } | ||
+ | #quote p.testimonial{ | ||
+ | font-size: 12px; | ||
+ | font-family: Arial, Helvetica, sans-serif; | ||
+ | font-style: normal; | ||
+ | color: #000; | ||
+ | margin-left:15px; | ||
+ | |||
+ | } | ||
+ | #quote .quote{ | ||
+ | font-size: 26px; | ||
+ | } | ||
+ | #contacts h2{ | ||
+ | margin-top: 20px; | ||
+ | } | ||
+ | |||
+ | |||
+ | |||
+ | .col_list ul{ | ||
+ | list-style-type:none; | ||
+ | list-style-image:none; | ||
+ | background-image:none; | ||
+ | } | ||
+ | .col_list li{ | ||
+ | background-color:#e1e6e9; | ||
+ | padding: 5px 15px; | ||
+ | } | ||
+ | |||
+ | .col_list_team ul{ | ||
+ | list-style-type:none; | ||
+ | list-style-image:none; | ||
+ | background-image:none; | ||
+ | } | ||
+ | .col_list_team li{ | ||
+ | background-color:#e1e6e9; | ||
+ | } | ||
+ | |||
+ | |||
+ | |||
+ | /* TEAM PAGE */ | ||
+ | |||
+ | |||
+ | .bio { | ||
+ | clear:both; | ||
+ | padding-bottom: 20px; | ||
+ | border-bottom: 1px solid #ccc; | ||
+ | } | ||
+ | .bio img { | ||
+ | float:left; | ||
+ | margin-right: 10px; | ||
+ | } | ||
+ | |||
+ | #videoiframe { | ||
+ | overflow: hidden; | ||
+ | margin-top: 20px; | ||
} | } | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
+ | #accordion .ui-accordion-content { padding: 0px 0px 0px 0px; } | ||
</style> | </style> |
Revision as of 23:47, 20 March 2012
Basically Acid: Bacteria that fix acid reflux
|
Team
Our team currently consists of six students from Sharon High School that share an interest in biology. We are also guided by two high school biology teachers that have prior experience with iGEM.
Teachers
James Dixon
Zach Snow
Students
Rohit Krishnan
Leanne Lupone
Prashant Maddineni
Scott Xiong
Max Glanz
Luke Emery-Fertitta
Vithusha Thirumavalavan
Evan Kates
Project
What are you working on this semester?
This semester, we are working on engineering a bacteria with a pH sensor that will activate a gene in the presence of gastric acid (pH of 1.5 to 3.5). The gene will then allow the bacteria to excrete a base or stomach mucus to help neutralize the gastric acid in the esophagus, which is the leading cause of Gastroesophageal Reflux Disease (GERD).
Notebook
Show us how you spent your days.
Fall 2011 - Learning the basics of the relevant biology
Winter 2012 - Brainstorming possible topics for our project.
3/6/12 - We settled on further investigating the use of a biological medicine to relieve the symptoms of Gastric Reflux Disease. The internet has been our primary method of research. We have found an available pH sensor and researched the current market of GERD medicines. We are currently looking for our desired method of neutralizing the stomach acid.
3/13/12 - We are looking at another iGEM project which featured a bacteria that secretes a base.
3/20/12 - We are continuing research and focusing on updating the wiki for now.
Results/Conclusions
What did you achieve over the course of your semester?
Safety
What safety precautions did your team take? Did you take a safety training course? Were you supervised at all times in the lab?
Every member of our team has experience in multiple laboratories through school and have digested a variety of safety training documents and videos. Additionally, we are supervised by two AP biology teachers in all of our experiments.
Attributions
Wiki Page
Scott ~ Luke ~ Rohit
Fundraising
Prashant ~ Max
Research
Leanne ~ Vithusha
Human Practices
What impact does/will your project have on the public?
Similar to TUMS tablets, our bacteria helps relieve the pain cause by Gastroesophageal Reflux Disease. Some symptoms that we hope to relieve include heartburn, difficulty swallowing, and chest pain. To make the medicine more easily administered, it will take the form of a solution that can be taken either before or after a meal. One significant advantage of the biological engineering method is the ability to create sustainable bacteria. This will allow the administration of the bacteria to be preemptive in addressing the symptoms GERD, as opposed to the current system of administration after the onset of symptoms.
Considered Parts
Part:BBa_K174002